Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.

被引：0
|
作者：
O'Sullivan, Dylan E.
Brenner, Darren
Syed, Iqra
Shanahan, Mary Kate
Moldaver, Daniel
Sit, Christina
Bebb, D. Gwyn
Cheung, Winson Y.
Boyne, Devon J.
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] AstraZeneca Canada, Mississauga, ON, Canada
[3] AstraZeneca, Toronto, ON, Canada
[4] Lung Canc Canada, Toronto, ON, Canada
[5] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[6] Tom Baker Canc Clin, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e20575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20575
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Progress in the diagnosis and treatment of extensive-stage small cell lung cancer
    Fei Xu
    Xiaoli Ren
    Yuan Chen
    Qianxia Li
    Ruichao Li
    Yu Chen
    Shu Xia
    Oncology and Translational Medicine, 2019, 5 (01) : 33 - 42
  • [42] Clinical outcomes of atezolizumab in combination with etoposide/platinum for extensive-stage small cell lung cancer in China: A real-world, multi-center, retrospective, controlled study
    Zhuo, M.
    Chen, H.
    Ma, X.
    Liu, J.
    Yang, Y.
    Fang, Y.
    Wang, L.
    Zhao, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S100 - S100
  • [43] Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer
    Rittberg, Rebekah
    Leung, Bonnie
    Al-Hashami, Zamzam
    Ho, Cheryl
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study
    Misawa, Kazuhito
    Watanabe, Kageaki
    Seike, Masahiro
    Hosomi, Yukio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07) : 1585 - 1594
  • [45] Efficacy and safety of sintilimab in combination with chemotherapy for recurrent extensive-stage small cell lung cancer: a real-world retrospective study
    Wang, Jingyi
    Liang, Shuzhi
    Xu, Li
    Kong, Yi
    Seki, Nobuhiko
    Ganti, Apar Kishor
    Neal, Joel W.
    Li, Jia
    Xu, Fang
    Li, Kang
    Xu, Yan
    Wu, Lin
    Chen, Bolin
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3897 - 3908
  • [46] Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
    Arunachalam, Ashwini
    Sura, Sneha
    Murphy, John
    Conkling, Paul
    Goldschmidt, Jerome
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E13 - E13
  • [47] Real-world treatment patterns and outcomes among unresectable stage III non-small cell lung cancer
    Arunachalam, Ashwini
    Sura, Sneha
    Murphy, John
    Conkling, Paul
    Goldschmidt, Jerome
    PLOS ONE, 2024, 19 (11):
  • [48] Brazilian real-world data of immunotherapy in extensive stage small cell lung cancer
    Duarte, Flavia A.
    Dienstmann, Rodrigo
    Diniz, Paulo H. C.
    Silva, Matheus C. e
    Veloso, Gilson G. V.
    Arcanjo, Georgia S.
    Paes, Rafael
    Montella, Tatiane C.
    Lima, Helena F. C. A.
    Ferrari, Bruno L.
    Macuzo, Eliane V.
    Ferreira, Carlos G.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [49] Efficacy of immunotherapy for extensive-stage small cell esophageal cancer: A multicenter real-world retrospective study
    Fan, B.
    Qiu, X.
    Wang, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S102 - S102
  • [50] Real-World Outcomes in Patients with 3rd-Line Extensive Stage Small Cell Lung Cancer
    Bar, J.
    Xu, Q.
    Karve, S.
    Jeng, E. E.
    Alexandroff, S.
    Ready, N. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S704 - S704
12345